James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 4,300 shares at $85.18 ($366K) on 2018-11-08, disclosed to the SEC on 2018-11-13.
Open-market sale of $366k GHDX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.94 | 1,100 | $92K | 25.2% |
| 2 | $85.18 | 1,300 | $111K | 30.2% |
| 3 | $85.18 | 1,300 | $111K | 30.2% |
| 4 | $85.84 | 300 | $26K | 7.0% |
| 5 | $89.07 | 300 | $27K | 7.3% |
| Total | $85.18 avg | 4,300 |
| $366K |
| 100% |
| Filing → |
| GHDX | SELL | 2019-08-12 | $332K | — | Filing → |
| GHDX | SELL | 2019-07-09 | $399K | — | Filing → |
| GHDX | SELL | 2019-06-10 | $61K | — | Filing → |